Respiratory Case Reports
4.
Martin LW, Correa AM, Ordonez NG, Roth JA, Swisher SG, Vaporciyan AA, et al. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg 2007; 84:973-80. [CrossRef]
5.
Nakajima M1, Kasai T, Hashimoto H, Iwata Y, Manabe H. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases. Cancer 1999; 86:608-16. [CrossRef]
6.
Ishida T, Tateishi M, Kaneko S, Yano T, Mitsudomi T, Sugimachi K, et al. Carcinosarcoma and spindle cell carcinoma of the lung. Clinicopathologic and immunohistochemical studies. J Thorac Cardiovasc Surg 1990; 100:844-52.
7.
Davis MP, Eagan RT, Weiland LH, Pairolero PC. Carcinosarcoma of the lung: Mayo Clinic experience and response to chemotherapy. Mayo Clin Proc 1984; 59:598603. [CrossRef]
8.
Humphrey PA1, Scroggs MW, Roggli VL, Shelburne JD. Pulmonary carcinomas with a sarcomatoid element: an immunocytochemical and ultrastructural analysis. Hum Pathol 1988; 19:155-65. [CrossRef]
9.
Travis WD, Brambilla E, Müller-Hermelink K, Harris C, Kleihues C, Sobin P. Pathology and genetics of tumors of the lung, pleura, thymus, and heart. World Health Organization Classification of Tumours. Lyon: IARC Press; 2004. p. 53-58. http://www.iarc.fr/en/publications/pdfsonline/pat-gen/bb10/BB10
10. Huwer H, Kalweit G, Straub U, Feindt P, Volkmer I, Gams E. Pulmonary carcinosarcoma: diagnostic problems and determinants of the prognosis. Eur J Cardiothorac Surg 1996; 10:403–7. [CrossRef] 11. Kim KI, Flint JD, Müller NL. Pulmonary carcinosarcoma: radiologic and pathologic findings in three patients. AJR Am J Roentgenol 1997; 169:691–4. [CrossRef]
13. Travis WD. Sarcomatoid neoplasms of the lung and pleura. Arch Pathol Lab Med 2010; 134:1645-58. [CrossRef] 14. Vieira T, Antoine M, Ruppert AM, Fallet V, Duruisseaux M, Giroux Leprieur E, et al. Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung. Lung Cancer 2014; 85:276-81. [CrossRef] 15. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015;10: 1243-60. [CrossRef] 16. Velcheti V, Rimm DL, Schalper KA. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1); J Thorac Oncol 2013; 8: 803–5. [CrossRef] 17. Braham E, Ben Rejeb H, Aouadi S, Kilani T, El Mezni F. Pulmonary carcinosarcoma with heterologous component: report of two cases with literature review. Ann Transl Med 2014; 2:41. [CrossRef] 18. Sugano T, Mori M, Namba Y, Uenami T, Kagami S, Yokota S. A case of sarcomatoid carcinoma of the lung successfully treated with carboplatin, paclitaxel and bevacizumab. Nihon Kokyuki Gakkai Zasshi 2011; 49:304-8. 19. Langer F, Wintzer HO, Werner M, Weber C, Brümmendorf TH, Bokemeyer C. A case of pulmonary carcinosarcoma (squamous cell carcinoma and osteosarcoma) treated with cisplatin and doxorubicin. Anticancer Res 2006; 26:3893-7. 20. Pelosi G1, Sonzogni A, De Pas T, Galetta D, Veronesi G, Spaggiari L, et al., Pulmonary sarcomatoid carcinomas: a practical overview Int J Surg Pathol 2010; 18:103-20. [CrossRef]
12. Koss MN, Hochholzer L, Frommelt RA. Carcinosarcomas of the lung: a clinicopathologic study of 66 patients. Am J Surg Pathol 1999; 23:1514–26. [CrossRef]
Cilt - Vol. 6 Sayı - No. 2
77